Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2Phase 2 1

Status

Completed 3Withdrawn 1Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 3

Conditions

Neoplasms 10Breast Neoplasms 6Recurrence 4Lymphoma, Non-Hodgkin 4Leukemia, Myeloid, Acute 4Hematologic Neoplasms 4Wilms Tumor 3Solid Tumor 3Neuroblastoma 3Neoplasm Metastasis 3Multiple Myeloma 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3Lymphoma 3Leukemia, Lymphocytic, Chronic, B-Cell 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Basal Cell 3Testicular Neoplasms 2Skin Neoplasms 2Sezary Syndrome 2Prostatic Neoplasms 2Primary Myelofibrosis 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neutropenia 2Mycosis Fungoides 2Mycoses 2Medical Oncology 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2

Interventions

HhAntag691 18Imiquimod 10sonidegib 8Photochemotherapy 71-phenyl-3,3-dimethyltriazene 6methyl 5-aminolevulinate 4Surgical Procedures, Operative 4Biopsy 4Aminolevulinic Acid 4cemiplimab 3Mohs Surgery 3Microscopy, Confocal 3Itraconazole 3IPI-926 33-ingenyl angelate 3tazarotene 2Microarray Analysis 2Laser Therapy 2Gene Expression Profiling 2Eflornithine 2Drug Evaluation 2Acitretin 2tozuleristide 1teriflunomide 1talimogene laherparepvec 1silmitasertib 1remetinostat 1pembrolizumab 1gusacitinib 1green tea extract polyphenone E 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Carcinoma, Basal Cell × Itraconazole × Clear all
NCT02120677 2020-12-16

Topical Itraconazole in the Treatment of Basal Cell Carcinoma

Johns Hopkins University

Phase EARLY_PHASE1 Completed
5 enrolled
Dermatologic

Carcinoma, Basal Cell, Skin Neoplasms

NCT02735356 2019-04-11

Topical Itraconazole in Treating Patients With Basal Cell Cancer

Stanford University

Phase EARLY_PHASE1 Completed
9 enrolled
Dermatologic

Carcinoma, Basal Cell

NCT01108094 2018-11-13

Pilot Biomarker Trial to Evaluate the Efficacy of Itraconazole in Patients w/ Basal Cell Carcinomas

Stanford University

Phase 2 Completed
29 enrolled 13 charts
Dermatologic

Carcinoma, Basal Cell, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡